TABLE 1 LAMEA Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 3 LAMEA Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 4 LAMEA Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 5 LAMEA Mono Drug Therapy Market by Country, 2017 - 2020, USD Million
TABLE 6 LAMEA Mono Drug Therapy Market by Country, 2021 - 2027, USD Million
TABLE 7 LAMEA Combination Drug Therapy Market by Country, 2017 - 2020, USD Million
TABLE 8 LAMEA Combination Drug Therapy Market by Country, 2021 - 2027, USD Million
TABLE 9 LAMEA Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 10 LAMEA Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 11 LAMEA Alpha Blockers Market by Country, 2017 - 2020, USD Million
TABLE 12 LAMEA Alpha Blockers Market by Country, 2021 - 2027, USD Million
TABLE 13 LAMEA 5- alpha Reductase Inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 14 LAMEA 5- alpha Reductase Inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 15 LAMEA Phosphodiesterase-5 Inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA Phosphodiesterase-5 Inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 17 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 18 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 19 LAMEA Benign Prostatic Hyperplasia Therapeutics Market by Country, 2017 - 2020, USD Million
TABLE 20 LAMEA Benign Prostatic Hyperplasia Therapeutics Market by Country, 2021 - 2027, USD Million
TABLE 21 Brazil Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 22 Brazil Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 23 Brazil Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 24 Brazil Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 25 Brazil Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 26 Brazil Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 27 Argentina Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 28 Argentina Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 29 Argentina Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 30 Argentina Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 31 Argentina Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 32 Argentina Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 33 UAE Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 34 UAE Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 35 UAE Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 36 UAE Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 37 UAE Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 38 UAE Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 39 Saudi Arabia Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 40 Saudi Arabia Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 41 Saudi Arabia Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 42 Saudi Arabia Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 43 Saudi Arabia Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 44 Saudi Arabia Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 45 South Africa Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 46 South Africa Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 47 South Africa Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 48 South Africa Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 49 South Africa Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 50 South Africa Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 51 Nigeria Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 52 Nigeria Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 53 Nigeria Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 54 Nigeria Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 55 Nigeria Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 56 Nigeria Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 57 Rest of LAMEA Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 58 Rest of LAMEA Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 59 Rest of LAMEA Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 60 Rest of LAMEA Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 61 Rest of LAMEA Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 62 Rest of LAMEA Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 63 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 64 key information – Astellas Pharma, Inc.
TABLE 65 Key Information – Eli Lilly and Company
TABLE 66 Key Information – Allergan PLC
TABLE 67 key Information – Merck Group
TABLE 68 Key Information – Boehringer Ingelheim International GmbH
TABLE 69 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 70 Key Information – Sanofi S.A.
TABLE 71 Key Information – Pfizer, Inc.
TABLE 72 Key Information – Abbott Laboratories
List of Figures
FIG 1 Methodology for the research
Unique Offerings 